STRYKER CORP SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account
STRYKER CORP (SYK) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account of $11.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-13.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts · last filed 2014-02-13
- STRYKER CORP sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for fiscal 2013 was $11.00M, a 37.50% increase from fiscal 2012.
- STRYKER CORP sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for fiscal 2012 was $8.00M, a 11.11% decline from fiscal 2011.
- STRYKER CORP sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for fiscal 2011 was $9.00M, a 70.00% decline from fiscal 2010.
- STRYKER CORP sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for fiscal 2010 was $30.00M, a 328.57% increase from fiscal 2009.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account 12 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account 12 month as first filed |
|---|---|---|
| 2013-12-31 | $11.00M 10-K · filed 2014-02-13 | |
| 2012-12-31 | $8.00M 10-K · filed 2014-02-13 | |
| 2011-12-31 | $9.00M 10-K · filed 2014-02-13 | |
| 2010-12-31 | $30.00M 10-K · filed 2013-02-27 | $29.80M 10-K · filed 2011-02-18 |
| 2009-12-31 | $7.00M 10-K · filed 2012-02-13 | $6.60M 10-K · filed 2011-02-18 |
| 2008-12-31 | $10.20M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |